Advertisement

Management of Cerebral Venous Thrombosis

  • Xiaomeng Xu
  • Magdy SelimEmail author
Chapter
  • 66 Downloads
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

Cerebral venous thrombosis (CVT) is a rare disease with an incidence of 15 cases per million people per year. However, it is an important cause of stroke, particularly in young patients. The clinical presentation of CVT is highly variable and the symptoms are nonspecific, making early diagnosis challenging. Confirming the diagnosis of CVT requires a high degree of clinical suspicion and brain imaging. Magnetic resonance imaging of the brain and venography are the preferred imaging techniques. Early diagnosis and treatment are essential for improved outcomes. Anticoagulation for 3–12 months is often advocated. The prognosis of CVT is better than arterial stroke with prompt diagnosis and treatment. This chapter will review the epidemiology, clinical presentation, recommended diagnostic workup, and treatment of CVT.

Keywords

Cerebral venous thrombosis Computed tomography venography Magnetic resonance venography Anticoagulation Heparin Low-molecular-weight heparin Warfarin 

References

  1. 1.
    Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis: a cross-sectional study. Stroke. 2012;43(12):3375–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Devasagayam S, Wyatt B, Leyden J, Kleinig T. Cerebral venous sinus thrombosis incidence is higher than previously thought: a retrospective population-based study. Stroke. 2016;47(9):2180–2.PubMedCrossRefGoogle Scholar
  3. 3.
    Silvis SM, de Sousa DA, Ferro JM, Coutinho JM. Cerebral venous thrombosis. Nat Rev Neurol. 2017;13(9):555–65.PubMedCrossRefGoogle Scholar
  4. 4.
    Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F, Investigators I. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke. 2005;36(9):1927–32.PubMedCrossRefGoogle Scholar
  5. 5.
    Ferro JM, Canhao P. Cerebral venous sinus thrombosis: update on diagnosis and management. Curr Cardiol Rep. 2014;16(9):523.PubMedCrossRefGoogle Scholar
  6. 6.
    Kovacs MJ. Letter by Kovacs regarding article, Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(7):e408.PubMedCrossRefGoogle Scholar
  7. 7.
    Aguiar de Sousa D, Canhao P, Crassard I, Coutinho J, Arauz A, Conforto A, et al. Safety of pregnancy after cerebral venous thrombosis: results of the ISCVT (International Study on Cerebral Vein and Dural Sinus Thrombosis)-2 pregnancy study. Stroke. 2017;48(11):3130–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(4):1158–92.PubMedCrossRefGoogle Scholar
  9. 9.
    Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry. 2005;76(8):1084–7.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol. 2007;6(2):162–70.PubMedCrossRefGoogle Scholar
  11. 11.
    Alvis-Miranda HR, Milena Castellar-Leones S, Alcala-Cerra G, Rafael Moscote-Salazar L. Cerebral sinus venous thrombosis. J Neurosci Rural Pract. 2013;4(4):427–38.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Provenzale JM, Joseph GJ, Barboriak DP. Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls. AJR Am J Roentgenol. 1998;170(3):777–83.PubMedCrossRefGoogle Scholar
  13. 13.
    Rao KC, Knipp HC, Wagner EJ. Computed tomographic findings in cerebral sinus and venous thrombosis. Radiology. 1981;140(2):391–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Zeina AR, Kassem E, Klein A, Nachtigal A. Hyperdense cerebral sinus vein thrombosis on computed tomography. West J Emerg Med. 2010;11(2):217.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Ferro JM, Bousser MG, Canhao P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. Eur J Neurol. 2017;24(10):1203–13.PubMedCrossRefGoogle Scholar
  16. 16.
    Long B, Koyfman A, Runyon MS. Cerebral venous thrombosis: a challenging neurologic giagnosis. Emerg Med Clin North Am. 2017;35(4):869–78.PubMedCrossRefGoogle Scholar
  17. 17.
    Kosinski CM, Mull M, Schwarz M, Koch B, Biniek R, Schlafer J, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke. 2004;35(12):2820–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Investigators I. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35(3):664–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Ferro JM, Bacelar-Nicolau H, Rodrigues T, Bacelar-Nicolau L, Canhao P, Crassard I, et al. Risk score to predict the outcome of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2009;28(1):39–44.PubMedCrossRefGoogle Scholar
  20. 20.
    Koopman K, Uyttenboogaart M, Vroomen PC, van der Meer J, De Keyser J, Luijckx GJ. Development and validation of a predictive outcome score of cerebral venous thrombosis. J Neurol Sci. 2009;276(1–2):66–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338(8767):597–600.PubMedCrossRefGoogle Scholar
  22. 22.
    de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke. 1999;30(3):484–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Stam J, De Bruijn SF, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev. 2002;(4):CD002005.Google Scholar
  24. 24.
    Misra UK, Kalita J, Chandra S, Kumar B, Bansal V. Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol. 2012;19(7):1030–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Coutinho JM, Ferro JM, Zuurbier SM, Mink MS, Canhao P, Crassard I, et al. Thrombolysis or anticoagulation for cerebral venous thrombosis: rationale and design of the TO-ACT trial. Int J Stroke. 2013;8(2):135–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Siddiqui FM, Dandapat S, Banerjee C, Zuurbier SM, Johnson M, Stam J, et al. Mechanical thrombectomy in cerebral venous thrombosis: systematic review of 185 cases. Stroke. 2015;46(5):1263–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin. 1992;10(1):87–111.PubMedCrossRefGoogle Scholar
  28. 28.
    Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, Massaro A, et al. Delay in the diagnosis of cerebral vein and dural sinus thrombosis: influence on outcome. Stroke. 2009;40(9):3133–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Biousse V, Ameri A, Bousser MG. Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology. 1999;53(7):1537–42.PubMedCrossRefGoogle Scholar
  30. 30.
    Hanley DF, Feldman E, Borel CO, Rosenbaum AE, Goldberg AL. Treatment of sagittal sinus thrombosis associated with cerebral hemorrhage and intracranial hypertension. Stroke. 1988;19(7):903–9.PubMedCrossRefGoogle Scholar
  31. 31.
    Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007;6(3):215–22.CrossRefGoogle Scholar
  32. 32.
    Canhao P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, et al. Are steroids useful to treat cerebral venous thrombosis? Stroke. 2008;39(1):105–10.PubMedCrossRefGoogle Scholar
  33. 33.
    Masuhr F, Busch M, Amberger N, Ortwein H, Weih M, Neumann K, et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol. 2006;13(8):852–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Sha DJ, Qian J, Gu SS, Wang LN, Wang F, Xu Y. Cerebral venous sinus thrombosis complicated by seizures: a retrospective analysis of 69 cases. J Thromb Thrombolysis. 2018;45(1):186–91.PubMedCrossRefGoogle Scholar
  35. 35.
    Greinacher A. Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252–61.PubMedCrossRefGoogle Scholar
  36. 36.
    Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):311S–37S.PubMedCrossRefGoogle Scholar
  37. 37.
    Warkentin TE, Greinacher A. Management of heparin-induced thrombocytopenia. Curr Opin Hematol. 2016;23(5):462–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, et al. Treatment and prevention of heparin-induced thrombocytopenia: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e495S–530S.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Geisbusch C, Richter D, Herweh C, Ringleb PA, Nagel S. Novel factor xa inhibitor for the treatment of cerebral venous and sinus thrombosis: first experience in 7 patients. Stroke. 2014;45(8):2469–71.PubMedCrossRefGoogle Scholar
  40. 40.
    Mendonca MD, Barbosa R, Cruz-e-Silva V, Calado S, Viana-Baptista M. Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. Int J Stroke. 2015;10(7):1115–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database Syst Rev. 2014;(2):CD001689.Google Scholar
  42. 42.
    Aguiar de Sousa D, Canhao P, Ferro JM. Safety of pregnancy after cerebral venous thrombosis: a systematic review. Stroke. 2016;47(3):713–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Stroke Division, Department of NeurologyBeth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA
  2. 2.Division of Stroke and Cerebrovascular Disease, Department of NeurologyBeth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA

Personalised recommendations